Pharma B2B eCommerce Market by Business Model (B2B2B, B2B2C), Product Type, Therapeutic Area, Distribution Type

List of Tables

The Pharma B2B eCommerce Market is projected to reach USD 47.27 billion by 2030 from USD 26.16 billion in 2022, at a CAGR of 7.67% during the forecast period.

Global Pharma B2B eCommerce Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 26.16 billion
Estimated Year Value [2023]	USD 28.11 billion
Forecast Year Value [2030]	USD 47.27 billion
CAGR (%)	7.67%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Pharma B2B eCommerce Market.

Based on Business Model, market is studied across B2B2B and B2B2C. The B2B2B is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Over-the-Counter (OTC) Products and Prescription Drugs. The Prescription Drugs is further studied across Diabetes Management, Specialty Care, and Vaccines. The Over-the-Counter (OTC) Products is projected to witness significant market share during forecast period.

Based on Therapeutic Area, market is studied across Cardiovascular, Dermatology, Gastroenterology, Infectious Diseases, Neurology, Oncology, and Respiratory. The Infectious Diseases is projected to witness significant market share during forecast period.

Based on Distribution Type, market is studied across Distributor/Wholesaler-Owned Digital eCommerce and Pharmaceutical Manufacturer-Owned Digital eCommerce. The Pharmaceutical Manufacturer-Owned Digital eCommerce is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Pharma B2B eCommerce Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Pharma B2B eCommerce Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Pharma B2B eCommerce Market, highlighting leading vendors and their innovative profiles. These include Amazon.com, Inc., AmerisourceBergen Corporation, Ayro Retail Solutions Pvt. Ltd, Becton, Dickinson & Company, Biddano Pvt Ltd., Cardinal Health, Inc., Cloudfy Ltd., Corevist, Inc., Divante S.A., Entersoft SA, Eurofins Scientific, EuroPlux, GXgate, Henry Schein, Inc., hystrix medical AG, Invertus, Mckesson Corporation, Medcombo by Behmpat Producciones S.L, Medideals Resources LLP, Merck KGaA, Ochre Media Pvt Ltd, Oro, Inc., Pharma Vends by Hivends Info Solutions Pvt. Ltd, Pharmaflair, Pharmaoffer, PHARMATRADZ, Piegon Media Pvt. Ltd., PipelinePharma, Remedial Health Solutions Limited, Sandoz by Novartis AG, Thermo Fisher Scientific, Inc., TrueCommerce Inc., Trxade, Health Inc., Wizarma Healthcare Private Limited, and Yaoshibang.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Pharma B2B eCommerce Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Pharma B2B eCommerce Market?

3. What is the competitive strategic window for identifying opportunities in the Pharma B2B eCommerce Market?

4. What are the latest technology trends and regulatory frameworks in the Pharma B2B eCommerce Market?

5. What is the market share of the leading vendors in the Pharma B2B eCommerce Market?

6. Which modes and strategic moves are suitable for entering the Pharma B2B eCommerce Market?

Product Code: MRR-2F11EB639CB8

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Pharma B2B eCommerce Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Embracing digital transformation in pharmacies and healthcare providers
  - 5.1.1.2. Improve the procurement process with purchase controls and reduce the complexity of carriage handling
  - 5.1.1.3. Need to maintain regulatory control and traceability in pharma with restricted catalogs
- 5.1.2. Restraints
  - 5.1.2.1. Complex integration of eCommerce platforms with the existing systems
- 5.1.3. Opportunities
  - 5.1.3.1. Rapid growth in developing personalized approaches and improving the customer experiences
  - 5.1.3.2. Increasing investment to improve the operational efficiencies of pharma B2B eCommerce platforms
- 5.1.4. Challenges
  - 5.1.4.1. Issues associated with the counterfeit and quality concerns of the pharma products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Pharma B2B eCommerce Market, by Business Model

6.1. Introduction
6.2. B2B2B
6.3. B2B2C

7. Pharma B2B eCommerce Market, by Product Type

7.1. Introduction
7.2. Over-the-Counter (OTC) Products
7.3. Prescription Drugs
- 7.4.1. Diabetes Management
- 7.4.2. Specialty Care
- 7.4.3. Vaccines

8. Pharma B2B eCommerce Market, by Therapeutic Area

8.1. Introduction
8.2. Cardiovascular
8.3. Dermatology
8.4. Gastroenterology
8.5. Infectious Diseases
8.6. Neurology
8.7. Oncology
8.8. Respiratory

9. Pharma B2B eCommerce Market, by Distribution Type

9.1. Introduction
9.2. Distributor/Wholesaler-Owned Digital eCommerce
9.3. Pharmaceutical Manufacturer-Owned Digital eCommerce

10. Americas Pharma B2B eCommerce Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pharma B2B eCommerce Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Pharma B2B eCommerce Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. New Product Launch & Enhancement
  - 13.3.1.1. Asian Healthcare Group Develops Vital High-Tech Platform, Beating Back COVID-19
- 13.3.2. Investment & Funding
  - 13.3.2.1. Saveo Raises USD 4.5 Mn To Streamline B2B Pharma Supply Chain
- 13.3.3. Award, Recognition, & Expansion
  - 13.3.3.1. Udaan Announces '4x4 Delivery Service' For Pharmacies

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Amazon.com, Inc.
- 14.1.2. AmerisourceBergen Corporation
- 14.1.3. Ayro Retail Solutions Pvt. Ltd
- 14.1.4. Becton, Dickinson & Company
- 14.1.5. Biddano Pvt Ltd.
- 14.1.6. Cardinal Health, Inc.
- 14.1.7. Cloudfy Ltd.
- 14.1.8. Corevist, Inc.
- 14.1.9. Divante S.A.
- 14.1.10. Entersoft SA
- 14.1.11. Eurofins Scientific
- 14.1.12. EuroPlux
- 14.1.13. GXgate
- 14.1.14. Henry Schein, Inc.
- 14.1.15. hystrix medical AG
- 14.1.16. Invertus
- 14.1.17. Mckesson Corporation
- 14.1.18. Medcombo by Behmpat Producciones S.L
- 14.1.19. Medideals Resources LLP
- 14.1.20. Merck KGaA
- 14.1.21. Ochre Media Pvt Ltd
- 14.1.22. Oro, Inc.
- 14.1.23. Pharma Vends by Hivends Info Solutions Pvt. Ltd
- 14.1.24. Pharmaflair
- 14.1.25. Pharmaoffer
- 14.1.26. PHARMATRADZ
- 14.1.27. Piegon Media Pvt. Ltd.
- 14.1.28. PipelinePharma
- 14.1.29. Remedial Health Solutions Limited
- 14.1.30. Sandoz by Novartis AG
- 14.1.31. Thermo Fisher Scientific, Inc.
- 14.1.32. TrueCommerce Inc.
- 14.1.33. Trxade, Health Inc.
- 14.1.34. Wizarma Healthcare Private Limited
- 14.1.35. Yaoshibang
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing